Moderna ( (MRNA) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Moderna’s stock has seen a decline following reports that link COVID-19 vaccines to child deaths, causing investor concern. Despite this, analysts maintain that there is still considerable upside potential for the company. The market remains uncertain as the implications of these reports on future vaccine policies are yet to be determined.
More about Moderna
YTD Price Performance: -39.55%
Average Trading Volume: 9,443,022
Technical Sentiment Signal: Sell
Current Market Cap: $9.88B
For further insights into MRNA stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.